A Clinical Study of iPSC-Derived Islet Cells for Diabetes Mellitus Therapy
A Clinical Study of iPSC-Derived Islet Cells for Diabetes Mellitus Therapy
Not yet recruiting · NCT07464119 · Registry updated 2026-03-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Study of iPSC-Derived Islet Cells for Diabetes Mellitus Therapy | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease | Not yet recruiting | Not applicable | 2026-03-11 | NCT07464119 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hangzhou Reprogenix Bioscience, Inc | 3 |
| Peking University First Hospital | 225 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Peking University First Hospital | Beijing | China | 72 |